Net Income (Loss) Attributable to Parent in USD of HELIUS MEDICAL TECHNOLOGIES, INC. from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
HELIUS MEDICAL TECHNOLOGIES, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q3 2025.
  • HELIUS MEDICAL TECHNOLOGIES, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$353M, a 9470% decline year-over-year.
  • HELIUS MEDICAL TECHNOLOGIES, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$370M, a 4081% decline year-over-year.
  • HELIUS MEDICAL TECHNOLOGIES, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$11.7M, a 32.7% decline from 2023.
  • HELIUS MEDICAL TECHNOLOGIES, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.85M, a 37.1% increase from 2022.
  • HELIUS MEDICAL TECHNOLOGIES, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.1M, a 22.4% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

HELIUS MEDICAL TECHNOLOGIES, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$370M -$353M -$349M -9470% 01 Jul 2025 30 Sep 2025 10-Q 18 Nov 2025
Q2 2025 -$21.3M -$9.83M -$8.22M -510% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$13.1M -$3.84M -$1.32M -52.5% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 -$11.7M -$3.93M -$2.88M -276% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025
Q3 2024 -$8.86M -$3.69M -$23K -0.63% 01 Jul 2024 30 Sep 2024 10-Q 18 Nov 2025
Q2 2024 -$8.84M -$1.61M +$36K +2.18% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$8.87M -$2.52M -$22K -0.88% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 -$8.85M -$1.05M +$3.84M +78.6% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 -$12.7M -$3.66M -$2.63M -256% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$10.1M -$1.65M +$2.16M +56.7% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$12.2M -$2.49M +$1.85M +42.6% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$14.1M -$4.89M -$784K -19.1% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$13.3M -$1.03M +$3.66M +78% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$16.9M -$3.81M +$2.17M +36.3% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$19.1M -$4.35M -$984K -29.3% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$18.1M -$4.1M -$1.57M -61.8% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023
Q3 2021 -$16.6M -$4.69M -$1.21M -34.8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$15.4M -$5.98M -$2.62M -78% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$12.7M -$3.36M +$1.4M +29.3% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$14.1M -$2.54M +$2.8M +52.4% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 -$16.9M -$3.48M +$2.11M +37.8% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$19M -$3.36M -$3.18M -1707% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$15.9M -$4.76M -$6.08M -459% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$9.78M -$5.33M -$216K -4.22% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2021
Q3 2019 -$9.57M -$5.59M -$1.07M -23.7% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$8.49M -$186K +$17.6M +99% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$26.1M $1.32M +$2.49M 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$28.6M -$5.12M -$1.39M -37.2% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 -$27.2M -$4.52M +$8.42M +65.1% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$35.7M -$17.8M -$12.1M -214% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 -$23.5M -$1.17M +$4.51M +79.5% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 -$28M -$3.73M 01 Oct 2017 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 -$12.9M -$9.95M -333% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$5.68M -$2.6M -84.1% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$5.68M -$1.85M -48.2% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q3 2016 -$12.3M -$2.99M -$4.77M -267% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 -$7.56M -$3.08M -$530K -20.7% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$7.03M -$3.83M -$1.79M -87.8% 01 Jan 2016 31 Mar 2016 10-Q 16 May 2017
Q4 2015 -$5.24M -$2.43M +$46.1K +1.86% 01 Oct 2015 31 Dec 2015 10-Q 26 Apr 2016
Q3 2015 -$5.29M $1.79M +$5.54M 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$10.8M -$2.55M -$990K -63.3% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$9.84M -$2.04M 01 Jan 2015 31 Mar 2015 10-K 28 Jun 2016
Q4 2014 -$2.48M 01 Oct 2014 31 Dec 2014 10-Q 26 Apr 2016
Q3 2014 -$3.76M 01 Jul 2014 30 Sep 2014 10-Q 26 Apr 2016
Q2 2014 -$1.56M 01 Apr 2014 30 Jun 2014 10-Q 26 Apr 2016
Q1 2013 -$8.52M 23 Jan 2013 31 Mar 2013 10-K 11 Jan 2016

HELIUS MEDICAL TECHNOLOGIES, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.7M -$2.89M -32.7% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 -$8.85M +$5.22M +37.1% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 -$14.1M +$4.06M +22.4% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$18.1M -$4M -28.3% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023
2020 -$14.1M -$4.35M -44.5% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022
2019 -$9.78M +$18.8M +65.8% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2021
2018 -$28.6M -$599K -2.14% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 -$28M 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019
2015 -$6.88M +$2.96M +30.1% 01 Apr 2015 31 Mar 2016 10-KT 03 Apr 2017
2014 -$9.84M -$8.77M -822% 01 Apr 2014 31 Mar 2015 10-K 28 Jun 2016
2013 -$1.07M +$7.45M +87.5% 01 Apr 2013 31 Mar 2014 10-K 11 Jan 2016
2012 -$8.52M 01 Apr 2012 31 Mar 2013 10-K 11 Jan 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.